Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Others

Items 31-40 of 106

Page
per page
  1. Obeticholic Acid
    B4888 Obeticholic Acid
     2 Citation
    Target: Farnesoid X receptors (FXRs)
    Summary: FXR agonist with anticholeretic activity
      ≥21.5 mg/mL
  2. YL-109
    B4857 YL-109
    Summary: novel anticancer agent
      insoluble in H2O; ≥11.4 mg/mL
  3. KN-93 Phosphate
    B4969 KN-93 Phosphate
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)
    Summary: CaM kinase II inhibitor, water soluble and cell permeable
      ≥29.95 mg/mL
  4. BPTES
    B6008 BPTES
    Target: Glutaminases
    Summary: GLS inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18 mg/mL
  5. Disodium (R)-2-Hydroxyglutarate
    B6018 Disodium (R)-2-Hydroxyglutarate
    Summary: inhibitor of α-ketoglutarate-dependent dioxygenases
      insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL
  6. Sodium Tauroursodeoxycholate (TUDC)
    B6019 Sodium Tauroursodeoxycholate (TUDC)
    Target: BCPCF efflux
    Summary: water soluble bile salt
      ≥26.1 mg/mL
  7. Palovarotene
    B1175 Palovarotene
    Target: RARs
    Summary: Selective retinoic acid receptor gamma(RAR-γ) agonist
      ≥41.5 mg/mL
  8. N6022
    B1111 N6022
    Target: S-nitrosoglutathione reductase
    Summary: GSNOR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  9. GSK 650394
    B1051 GSK 650394
     2 Citation
    Target: SGK
    Summary: SGK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.1 mg/mL
  10. Forskolin
    B1421 Forskolin
     2 Citation
    Target: Adenylyl Cyclases
    Summary: adenylate cyclase activator

Items 31-40 of 106

Page
per page
Relate Categories
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Category
  1. Actin2item
  2. Adenylate cyclase1 item
  3. ATP citrate lyase 1 item
  4. Calmodulin protein kinase II1 item
  5. CaM kinase II6item
  6. Cytokine1 item
  7. DHODH1 item
  8. FBPase1 item
  9. FXR2item
  10. Glycoprotein1 item
  11. GSNOR1 item
  12. GSTP1-11 item
  13. Guanylyl Cyclase1 item
  14. Hydroxylases1 item
  15. IMPDH1 item
  16. Inositol Phosphatases2item
  17. LXR2item
  18. MDR multidrug resistance1 item
  19. NAE2item
  20. NADPH Oxidase1 item
  21. Nampt1 item
  22. Nuclear Receptors3item
  23. Oxygenases/Oxidases1 item
  24. PDHK1 item
  25. RAR/RXR5item
  26. RARs4item
  27. Reagents4item
  28. Renin1 item
  29. Retinoid X Receptors1 item
  30. Squalene epoxidase2item
  31. SGK2item
  32. SPHK1 item
  33. Synthases/Synthetases1 item
  34. Thymidine phosphorylase1 item
  35. Transcription Factors3item
  36. β(1,3)-D-Glucan Synthase2item
  37. XAO1 item
  38. Others42item
  39. Renal Diseases1 item
Reversibility
  1. Reversible1 item
  2. Irreversible2item
Target
  1. Glycoproteins1 item
  2. AP-11 item
  3. MMP2item
  4. Thymidine Phosphorylases1 item
  5. Voltage-gated Potassium (KV) Channels1 item
  6. Farnesoid X receptors (FXRs)1 item
  7. P-glycoprotein (P-gp)1 item
  8. SGK2item
  9. Liver X receptors (LXRs)2item
  10. Neuraminidases (NA)1 item
  11. RARs8item
  12. ATP Citrate Lyases1 item
  13. Microtubules/Tubulins1 item
  14. Inositol Phosphatases1 item
  15. FAK1 item
  16. AMPK1 item
  17. Gutathione S-transferase1 item
  18. PDHK1 item
  19. eIF4E/eIF3G interaction1 item
  20. S-nitrosoglutathione reductase1 item
  21. Topoisomerases1 item
  22. Cytochrome P450 (CYP450)1 item
  23. Renin1 item
  24. Actin2item
  25. BMI-11 item
  26. Ca2 /calmodulin-dependent protein kinases (CaMKs)5item
  27. MLK31 item
  28. Protease-Activated Receptors1 item
  29. Calcium chelator1 item
  30. Sphingosine kinases (SphKs)1 item
  31. BCPCF efflux1 item
  32. D1 and D5 Receptors1 item
  33. D2 Receptors1 item
  34. D3 Receptors1 item
  35. Pancreatic and duodenal homeobox 1 (PDX1)1 item
  36. Angiotensin-Converting Enzymes (ACEs)1 item
  37. ROS and Other Gaseous Donors1 item
  38. C5a receptors1 item
  39. YAP1 item
  40. Cryptochromes1 item
  41. Squalene epoxidases2item
  42. Nampt1 item
  43. eIF4F1 item
  44. P2X Receptors1 item
  45. Glutaminases1 item
  46. Carbonic Anhydrases2item
  47. BLM1 item
  48. NADPH Oxidases2item
  49. Synthases/Synthetases2item
  50. TAK11 item
  51. Histamine H1 Receptors1 item
  52. RAR/RXR1 item
  53. Ionophores1 item
  54. Xanthine oxidoreductases1 item
  55. Dihydroorotate dehydrogenase1 item
  56. Guanylyl Cyclases1 item
  57. MNK1 item
  58. eEF-21 item
  59. Inward Rectifier Potassium (Kir) Channels1 item
  60. calcium chelator1 item
  61. Nuclear Receptors1 item
  62. fibrinolysis1 item
  63. D4 Receptors1 item
  64. Aldosterone receptor1 item
  65. NAE2item
  66. Ubiquitin-activating Enzyme E11 item
  67. SUMOylation1 item
  68. ATGL1 item
  69. Adenylyl Cyclases1 item
  70. Retinoic acid-related Orphan Receptors (RORs)1 item
  71. STK1 item
  72. Rev-Erb Receptors1 item
  73. Retinoid X receptors (RXR)1 item
  74. SHIP1 item
  75. FXR1 item
Reported Experiments
  1. Animal Experiments93item
  2. Cell Experiments69item
Related Disease
  1. Abscesses And Esophageal Candidiasis1 item
  2. Acute Disseminated Candidiasis1 item
  3. Acute Myeloid Leukemia2item
  4. Bladder Cancer1 item
  5. Brain Injuries Studies1 item
  6. Breast Cancer6item
  7. Cancer34item
  8. Candida Peritonitis1 item
  9. Candidemia1 item
  10. Colon Cancer5item
  11. Colorectal Cancer4item
  12. Diabetes1 item
  13. Dyslipidemia1 item
  14. Fungal Infection1 item
  15. Glioblastoma2item
  16. Glioma1 item
  17. Hepatocellular Carcinoma1 item
  18. HIV2item
  19. Inflammatory Diseases5item
  20. Leukemia1 item
  21. Lung Cancer4item
  22. Lymphoma5item
  23. Melanoma1 item
  24. Non-small Cell Lung Cancer2item
  25. Ovarian Cancer2item
  26. Pancreatic Cancer1 item
  27. Prostate Cancer1 item
  28. Psoriasis1 item
  29. Rheumatoid Arthritis1 item
  30. Schizophrenia1 item
  31. Squamous Cell Carcinoma1 item
  32. Type 2 Diabetes3item